Trademark: 79331573
Word
ASD - HIPROS
Status
Registered
Status Code
700
Status Date
Tuesday, December 27, 2022
Serial Number
79331573
Registration Number
6932819
Registration Date
Tuesday, December 27, 2022
Mark Type
4000
Filing Date
Friday, May 7, 2021
Published for Opposition
Tuesday, October 11, 2022

Trademark Owner History
Hovione Scientia Limited - Original Registrant

Classifications
5 Active pharmaceutical ingredients in the nature of pharmaceutical preparations, which are used for the prevention and treatment of disorders of the skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems of humans or animals; compositions for medical and veterinarian use, namely, chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; medical diagnostic compositions, namely medical diagnostic reagents; chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals
42 Development of pharmaceutical products and drug products; research on pharmaceutical products and drug products; research and development of new products in the pharmaceutical industry; Consulting services in the field of design and development of engineering processes for the pharmaceutical industry; research in the field of optimizing of manufacturing processes for the pharmaceutical industry

Trademark Events
May 10, 2023
Final Decision Transaction Processed By Ib
Apr 14, 2023
Final Disposition Notice Sent To Ib
Apr 13, 2023
Final Disposition Processed
Mar 27, 2023
Final Disposition Notice Created, To Be Sent To Ib
Feb 12, 2023
New Representative At Ib Received
Dec 27, 2022
Notice Of Registration Confirmation Emailed
Dec 27, 2022
Registered-Principal Register
Oct 11, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 11, 2022
Published For Opposition
Oct 10, 2022
Notification Processed By Ib
Sep 21, 2022
Notification Of Possible Opposition Sent To Ib
Sep 21, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 21, 2022
Notification Of Notice Of Publication E-Mailed
Sep 8, 2022
Approved For Pub - Principal Register
Aug 16, 2022
Teas/Email Correspondence Entered
Aug 16, 2022
Correspondence Received In Law Office
Aug 16, 2022
Teas Response To Office Action Received
Mar 22, 2022
Refusal Processed By Ib
Feb 28, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Feb 28, 2022
Refusal Processed By Mpu
Jan 29, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jan 28, 2022
Non-Final Action Written
Jan 25, 2022
Application Filing Receipt Mailed
Jan 21, 2022
Assigned To Examiner
Jan 21, 2022
New Application Office Supplied Data Entered
Jan 20, 2022
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24